Oppenheimer upgrades Mosaic on cost cuts and portfolio optimization

March 21, 2025 02:31 AM AEDT | By Investing
 Oppenheimer upgrades Mosaic on cost cuts and portfolio optimization
Oppenheimer upgrades Mosaic on cost cuts and portfolio optimization

Investing.com -- Oppenheimer upgraded The Mosaic Company (NYSE:MOS) to Outperform from Perform and set a price target of $33 given the fertilizer maker’s efforts to reduce costs, optimize its product portfolio, and boost production efficiency as key drivers of future growth.

Oppenheimer highlighted Mosaic’s internal initiatives to improve operations, which are expected to drive adjusted EBITDA to $3.3-3.5 billion by 2030.

“We believe the LT targets provide a scaffolding for helping investors get comfortable with the self-help opportunities, with the majority of those benefits expected to materialize in the next 12 months,” Oppenheimer said.

Mosaic’s turnaround in sulfuric acid facilities and normalized phosphate and potash production are expected to generate $600-650 million of EBITDA uplift by 2026, the largest contributor to the projected $650-800 million increase in adjusted EBITDA by 2030.

Phosphate production is expected to return to ~8 million tonnes by 2026. While Potash production is forecast to reach ~9 million tonnes by 2027.

Mosaic plans to reallocate $2-3 billion in capital by 2030, focusing on Tier 1 product investments and production assets while maintaining capital efficiencies. The company is also targeting a reduction in CapEx to below $850 million by 2030.

Mosaic’s differentiated market access is expected to provide a $100-150 million EBITDA uplift by 2030, driven by expanding performance product production, such as MicroEssentials, in Northern Brazil.

Selectively targeting regions in China and India, contributing $60-80 million of adjusted EBITDA uplift by 2030. Increasing North American penetration, adding ~$100 million in adjusted EBITDA by 2030.

Mosaic aims to grow beyond its core phosphate and potash markets by expanding into new products, including biologicals, which are expected to contribute ~$200 million in EBITDA by 2030 with profitability projected by Q4 2025.

Oppenheimer’s $33 price target is based on a 5.5x multiple of its updated 2026 EBITDA estimate of $2.62 billion. The firm cautioned that risks include a potential decline in corn prices, which could further hamper phosphate fertilizer demand.

“Our positive thesis assumes MOS execution against its operational turnaround,” Oppenheimer wrote.

This article first appeared in Investing.com


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.